Genentech sends “dear doctor” letters

Genentech has sent a “dear doctor” letter to warn about a higher risk for stroke in patients taking 0.5 mg of Lucentis, indicated for treating wet age-related macular degeneration.

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization. Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions